Citra Borneo Utama Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp795 (market cap 2.47T, 58.6K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 3.5× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 58.6K). Which is the better fit depends on your goals.
| CBUT | RSCH | |
|---|---|---|
Market Cap | 2.47T | 715.5B |
Volume | 58.6K | 30.64M |
Lot | 586 | 306.41K |
Turnover | 46.6M | 7.98B |
Average Price | 795.15 | 260.34 |
Value | 46.6M | 7.98B |
Indicative Equilibrium Price | 795 | 256 |
Indicative Equilibrium Volume | 1 | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →